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Background

Results

Multiple Sclerosis (MS) is a chronic inflammatory disease that
is characterized by demyelinating lesions throughout the
central nervous system that unpredictably occur at different
sites at different times. It affects approximately 400,000
people in the United States and 2.1 million people
worldwide.1 LVPG Neurology houses its own outpatient
infusion center, the CAHC LVPG Neurology Infusion Center, to
treat acute relapses for its MS patients with IV Solu-Medrol.
Currently, there is a low number of neurologist referrals for
IV Solu-Medrol infusion treatments for multiple sclerosis to
this in-office infusion center compared to its main
competing outpatient site - the Multipurpose Area (MPA), an
infusion center located in the LVHN Cancer Center of the
main hospital. It has had little publicity to the referring staff
since its establishment in 2013. Records indicate that from
November 2016 - January 2017, only 4 infusions were done at
the outpatient infusion clinic. From November 2017 - January
2018, only 1 infusion was completed. With approximately 1
infusion or less per month across the past two years,
facilities are largely underutilized (Graph 1). Based on the
cost of infusions for a relapse treatment prior to insurance
coverage, the in-office infusion center may be a more costeffective alternative to the MPA.

Conclusions

Graph 1: Running Chart of the Number of Infusions per
Month with Time
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Graph 2: Comparison of Average Infusions per Month
Pre-Intervention vs. Post-Intervention
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The educational intervention was successful when looking at
the number of completed infusions before and after the
intervention. The number of infusions on a monthly basis
showed that there was an increasing trend upward from
November 2018, following the educational intervention
(Graph 1). The average infusions per month at the in-office
infusion center increased by more than 8-fold, from 0.83 to
7 (Graph 2). Billing data showed that the MPA was more
expensive than the in-office infusion center, mainly due to
added facility fees (Table 1). An example cost of a relapse
infusion was much lower for the in-office infusion center
(Graph 3). When the total billed cost per relapse treatment
was multiplied by the post-interventional number of
infusions/month, the potential cost-savings of using the inoffice infusion center as opposed to the MPA was $12,026.00
in savings per month (Graph 4). Due to the success of this
intervention and potential cost-savings, future targeted
educational interventions with pre-assessment surveys would
likely be a promising model to further establish improved use
of the infusion center. A future automated referral option for
the in-office infusion center for providers would likely be the
next step forward.
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The purpose of this project is to increase the usage of
the CAHC LVPG Neurology Outpatient Infusion Center for
IV Solu-Medrol infusions by MS patients through a
targeted educational presentation and pamphlet for
referring physicians, physician’s assistants, and nurse
practitioners.

Table 1: Billing of Solu-

Outpatient Infusion Center MPA

Medrol Infusions

Methods

IV Solu-Medrol

$135.00

$188.00

Infusion Products

n/a

$65 x 2

Facility Fees/ Infusion Cost n/a

$1535

Total Cost

$135.00

$1853

Insurance Coverage

Full Coverage

Full Coverage

Implications

Graph 3: Total Cost Comparison of In-office Infusion
Center vs. MPA: Example of Total Billed for a Relapse
Treatment Prior to Insurance
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Graph 4: Estimated Average Monthly Billed Cost of InOffice Infusions vs. MPA Infusions (Prior to Insurance)
in the Post-Interventional Period
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An online 14-question survey (REDCap.com) was created and
distributed to physicians, physician assistants, and nurse
practitioners affiliated with the Department of Neurology.
The questionnaire addressed current referral patterns, the
awareness of the in-office infusion center, concerns
regarding referrals, rating of confidence in referring to the
in-office infusion center, and if the staff wishes to have
automated referrals to the treatment site. Information was
gathered from infusion staff through in-person interviews to
address concerns about the infusion enter. Cost of an
infusion experience at the MPA and in-office infusion center
was gathered from correspondence with the billing
department. Cost of the infusions prior to insurance were
compared. Data from the survey and interviews were
presented at a neurology conference in a videorecorded Powerpoint presentation with pamphlet
distribution. Pamphlets were designed as summaries of the
presentation and served as a concrete educational reference
for staff. The number of completed infusions at the in-office
infusion center during a 3-month period of November January of 2017 and 2018 were compared to the number of
infusions from the post-intervention period of November
2018 - January 2019. Comparison of the pre-interventional
and post-interventional data points were used as a
measurement of the efficacy of the intervention and were
translated to estimated cost savings by using the in-office
infusion center.

In-Office Infusion Center
4th Floor CAHC LVPG Neurology (Green Pod)
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The in-office infusion center, according to infusion center
staff, is more patient-centered when compared to the
services at the MPA. It has a higher staff to patient ratio and
gives a more personalized experience with a drawn curtain
for privacy, a room for only two patients, and musical or
televised entertainment. This is in comparison to the MPA,
which is an open facility where little privacy is given. There
is less nursing attention to each patient, due to the higher
frequency of usage by patients at a time. For the patient, it
may be a more satisfactory experience to use the in-office
infusion center with no difference in cost to them, as all
currently known insurances cover the treatments. In SELECT,
the focus of healthcare on the patient is essential. It is
important for the provider to know the patient’s values so
that he or she can utilize a treatment that allows the patient
to feel most comfortable. Values-based-patient-centeredcare (VBPCC) can be used to identify if a patient would
benefit from using the in-office infusion center, rather than
the MPA. From a health systems perspective, it is important
to evaluate cost-effectiveness and utilizing facilities
efficiently. The in-office infusion center was found to be less
expensive in total billing prior to insurance compared to the
MPA. With the difference in cost, the in-office infusion
center would be the more cost-effective option.
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